Date of AGM and Closing Date for Nomination of Director
Released
Released
Announcement PDF
ASX Announcement
18 May 2020
ASX Market Announcements
ASX Limited
Level 4
Stock Exchange Centre
20 Bridge Street
Sydney NSW 2000
Date of Annual General Meeting &
Closing Date for Nomination of Director
Melbourne, Australia, 18 May 2020 – In accordance with ASX Listing Rule 3.13.1, Avecho Biotechnology
Limited (ASX: AVE) (“Company”), an Australian drug delivery company, advises that its next Annual General
Meeting (“AGM”) will be held on Monday, 13 July 2020. An election of directors will be held at this AGM
pursuant to ASX Listing Rule 14.5. Details of the Director’s to be elected will be included in the forthcoming
Notice of AGM.
The Closing Date for receipt of nominations for the position of Director is Monday, 25 May 2020. Any
nominations must be received in writing no later than 5.00pm (Melbourne time) on Monday, 25 May 2020 at
the Company’s Registered Office.
The Company notes that the deadline for nominations for the position of Director is separate to voting on
Director elections. Details of the Director’s to be elected will be provided in the Company’s Notice of AGM in
due course.
For enquiries, please contact
Melanie Leydin
Company Secretary
+61 3 9692 7222
This announcement has been authorised by the Board of Directors of Avecho Biotechnology Limited.
About Avecho
Avecho Biotechnology Limited (ASX: AVE) develops and commercialises innovative Human and Animal Health
products using its proprietary drug delivery system called TPM® (Targeted Penetration Matrix). TPM® is
derived from Vitamin E using unique, proprietary and patented processes and is proven to enhance the
solubility and oral, dermal and transdermal absorption of drugs and nutrients.
Avecho’s major projects include delivering TPM® enhanced injectable, oral and topical products for the
human health market and is also developing TPM® to enhance the feed efficiency and health of livestock.
New additions to the development program include the recently announced application of TPM® to
cannabinoids.
See more here - avecho.com.au
Avecho Biotechnology Limited | ASX:AVE | ACN: 056 482 403 | ABN: 32 056 482 403
Unit 8A, 2A Westall Road, Hallmarc Business Park, Clayton VIC Australia 3168
avecho.com.au
Share your feedback
Discover